Changes in blood pressure, HbA1c, blood lipid and liver function-related indicator values compared with baseline values in all patients over time. by Jia Song (495396)

Each subfigure shows a different local size (LS) and context size (CS) configuration, where the reliability of the model across different initializations is measured in R-squared. by Eloy Geenjaar (21533195)

“…<p>In most cases where both the local size and context size is small, the DSVAE model is significantly more reliable than the IDSVAE method. However, for a local size of 8, the IDSVAE method is significantly more reliable when the context sizes are 2 or 8. …”

Description of the myofascial release techniques. by Sergio R. Thomaz (20308465)

Subjects:

Study flow diagram. by Sergio R. Thomaz (20308465)

Subjects:

Clinical characteristics of the study population. by Sergio R. Thomaz (20308465)

Subjects:

Average ratio of the concentrations obtained with qPCR, before and after DNase treatment, and with DAO before DNase treatment of the ISP phage stocks. by Saar Van Overfelt (20378458)

Average concentration of the ISP phage stocks obtained with qPCR, before and after DNase treatment, and with the DAO method before the DNase treatment. by Saar Van Overfelt (20378458)

Oxamate reduces cell viability, LDHA expression, and LDH activity in A549 and NCL-H1975 cells, enhancing the cytotoxic effect of LBP. by Siyu Yuan (7425719)

Quality of life and Beck Depression Inventory baseline and post CRT+MRT, CRT and RUHB. by Sergio R. Thomaz (20308465)

Subjects:

Cardiorespiratory variable measurement of the study population. by Sergio R. Thomaz (20308465)

Subjects:

Changes in maximal strength within each group after treatment. by Sergio R. Thomaz (20308465)

Subjects:

ΔQuality of life and ΔBeck Depression Inventory baseline and post CRT+MRT, CRT and RUHB. by Sergio R. Thomaz (20308465)

Subjects:

ΔVO₂ (ml/min), ΔVO₂/HR and ΔVE/VCO₂ slope baseline and post CRT+MRT, CRT and RUHB. by Sergio R. Thomaz (20308465)

Subjects:

Presentation 1_Decreased brain-derived neurotrophic factor expression in chronic kidney disease: integrated clinical and experimental evidence.pptx by Juan Chen (61123)

“…</p>Conclusion<p>This study integrated meta-analysis, murine model validation, and single-cell transcriptomic profiling to demonstrate a significant reduction of BDNF in CKD. Furthermore, renal BDNF expression decreased locally, predominantly originating from proximal tubule cells, macrophages, and podocytes, possibly epigenetically inhibited by the upregulation of lnc RNA Bdnf-as.…”

Transcriptome analysis. by Jiahao Zheng (807470)

Effect of Bcl-xL on proteins involved in the apoptotic pathway of MDCK cells. by Jiahao Zheng (807470)

Effect of Bcl-xl on the tumorigenicity of MDCK cells in nude mice. by Jiahao Zheng (807470)

Analysis and comparison of transcriptome data between WT and BY-02 cells. by Jiahao Zheng (807470)

Effects of compound 4f on neuroinflammation in mice with KA-induced neurodegeneration. by Naoto Arimura (416442)

Flow chart of experimental protocol. by Eun-Seon Yang (19751340)

“…SBP showed an increasing trend, but this was not statistically significant (<i>p</i> = 0.108). Interestingly, we observed significant decreases in arterial stiffness and PWV in POST_VM when comparing with PRE_VM (<i>p</i><0.001 and <i>p</i><0.001, respectively). …”